Financial flexibility takes top priority in Fresenius Medical Care’s financing strategy besides optimizing the financial costs. The company ensures this flexibility by using a wide range of financial instruments and securing a high level of diversification with regard to our investors and banks. Our financing profile is characterized by a wide spread of maturities up to 2024.
Our main financing instrument is the syndicated amended 2012 credit agreement with revolving credit facilities and loans in U.S. dollars and euros. In addition, in recent years, we have placed unsecured senior notes in euros and U.S. dollars. Furthermore, Fresenius Medical Care has sufficient financing flexibility in the form of credit facilities and an accounts receivable facility.